31. Contingencies and other financial commitments
Contingent liabilities relate to potential future events which, although regarded as improbable on the reporting date, cannot be ruled out and would create an obligation if they occurred.
Contingent liabilities resulted entirely from commitments given to third parties and comprised:
| Contingent Liabilities | [Table 4.92] | |
|---|---|---|
| Dec. 31, 2008 | Dec. 31, 2009 | |
| € million | € million | |
| Warranties | 114 | 74 |
| Miscellaneous | 591 | 601 |
| Total | 705 | 675 |
The miscellaneous contingent liabilities included an unpaid portion of the effective initial fund of Bayer-Pensionskasse amounting to €490 million, which may result in further payments by Bayer AG in subsequent years.
In addition to provisions, other liabilities and contingent liabilities, there were also other financial commitments. These mainly related to leasing agreements and long-term rentals.
The non-discounted minimum future payments relating to operating leases totaled €606 million (2008: €685 million). The maturities of the respective payment obligations were as follows:
| Operating Leases | [Table 4.93] | |||
|---|---|---|---|---|
| Maturing in | Dec. 31, 2008 | Maturing in | Dec. 31, 2009 | |
| € million | € million | |||
| 2009 | 205 | 2010 | 166 | |
| 2010 | 145 | 2011 | 132 | |
| 2011 | 113 | 2012 | 99 | |
| 2012 | 81 | 2013 | 72 | |
| 2013 | 65 | 2014 | 59 | |
| 2014 or later | 76 | 2015 or later | 78 | |
| Total | 685 | Total | 606 | |
Financial commitments resulting from orders already placed under purchase agreements related to planned or ongoing capital expenditure projects totaled €441 million (2008: €300 million).
In addition, the Group has entered into research agreements with a number of third parties under which Bayer has agreed to fund various research projects or has assumed other payment obligations based on the achievement of certain milestones or other specific conditions. The total amount of such funding and other commitments was €661 million (2008: €915 million). As of December 31, 2009, the remaining payments expected to be made to these parties, assuming the milestones are reached or the other agreed conditions are met in the respective years, were as follows:
| Other Commitments | [Table 4.94] | |||
|---|---|---|---|---|
| Maturing in | Dec. 31, 2008 | Maturing in | Dec. 31, 2009 | |
| € million | € million | |||
| 2009 | 127 | 2010 | 154 | |
| 2010 | 93 | 2011 | 114 | |
| 2011 | 110 | 2012 | 83 | |
| 2012 | 133 | 2013 | 39 | |
| 2013 | 71 | 2014 | 43 | |
| 2014 or later | 381 | 2015 or later | 228 | |
| Total | 915 | Total | 661 | |



Overview
Notes to the Consolidated Financial Statements of the Bayer Group
Bayer Links
Investor Relations


Advanced Search



